FRANKLIN
LAKES, N.J., March 26,
2024 /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX), a leading global medical technology company,
today was named to Fortune's 2024 list of America's Most
Innovative Companies.
"At BD, innovation is about a mindset of excellence and
continuous improvement, boldly challenging ourselves to think ahead
and partnering with our customers to understand the evolving needs
of the billions of patients around the world who rely on our health
care products and solutions," said Tom
Polen, chairman, CEO and president of BD. "This recognition
is a testament to our 70,000 associates who work every day, united
around our purpose, to deliver innovations that meaningfully
advance the standard of care and contribute to today's new,
transformational era of health care."
The ranking is built on three pillars:
- Product innovation: Evaluation of a company's
products and services, covering aspects from attractiveness and
design to usability and uniqueness;
- Process innovation: Analysis of all processes of a
company, from sourcing and production to marketing, sales and
support;
- Innovation culture: Extent to which a company
fosters a spirit of entrepreneurship and creativity internally and
allows employees to implement new ideas.
Fortune and Statista surveyed more than 35,000 employees
from eligible companies and 8,000 industry experts to rank
companies across the three categories, in addition to evaluating a
company's patents within the product innovation category. Of the
more than 25,000 U.S. companies considered, those with the highest
200 scores were named to Fortune's list of America's Most
Innovative Companies.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its more than
70,000 employees have a passion and commitment to help enhance the
safety and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please
visit bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/, X (formerly Twitter)
@BDandCo or Instagram
@becton_dickinson.
Contacts:
|
|
|
|
Media:
|
Investors:
|
Troy Kirkpatrick
|
Adam Reiffe
|
VP, Public
Relations
|
Sr. Director, Investor
Relations
|
858.617.2361
|
201.847.6927
|
troy.kirkpatrick@bd.com
|
adam.reiffe@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-named-among-fortunes-most-innovative-companies-302099637.html
SOURCE BD (Becton, Dickinson and Company)